Neuphoria Therapeutics To Be Acquired By Scancell In All-Share Deal; Combined Company To Seek $89M In Debt And Equity Financing Upon U.S. Listing
Scancell Holdings plc (AIM: SCLP) ("Scancell") and Neuphoria Therapeutics Inc. (NASDAQ:NEUP) ("Neuphoria") today announce an all-share merger in which Scancell will acquire Neuphoria. Upon completion of
Two medicine companies are joining together to become one bigger company. When companies merge, watch how the combined team plans to use their money and whether doctors and patients think their new medicines are helpful.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.